Impact for liver function of egg white protein.
Not Applicable
Completed
- Conditions
- Japanese males with underlying diseases
- Registration Number
- JPRN-UMIN000047776
- Lead Sponsor
- Toranomon Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Adults with underlying diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver stiffness measurement and fat deposition with abdominal ultrasonography Liver stiffness measurement with MRI Liver function test with blood sampling test.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does egg white protein modulate in liver function improvement for Japanese males with chronic disease?
How does egg white protein compare to standard dietary interventions in managing hepatic enzyme levels in NAFLD/NASH patients?
Which biomarkers correlate with liver function response to egg white protein supplementation in metabolically compromised individuals?
What adverse events are associated with egg white protein administration in patients with pre-existing liver conditions?
Are there synergistic effects of combining egg white protein with FXR agonists or HNF4α modulators for liver disease treatment?